Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids

Details for Australian Patent Application No. 2006206267 (hide)

Owner Introgen Therapeutics, Inc.

Inventors Zhang, Shuyuan; Chada, Sunil; Menander, Kerstin; Clarke, Peter; Sobol, Robert

Agent Pizzeys

Pub. Number AU-A-2006206267

PCT Pub. Number WO2006/079014

Priority 60/692,481 21.06.05 US; 60/645,826 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/88 (2006.01) Mutation or genetic engineering

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/079014 Priority application(s): WO2006/079014

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206270-Cover system for a boat

2006206259-Modular stent graft employing bifurcated graft and leg locking stent elements